GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord))

formerly Genuity ScienceAcquired

Genuity Science | Biological Data Insights to Accelerate Precision Medicine

Cambridge, United States · $530.0M raised

Business Model
B2B
Total Funding
$530.0M
Last Round
$200.0M Series CNov 2018
Rounds
4
Acquired by
HiberCellAug 2021

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Genuity Science is a privately-funded life sciences company headquartered in Dublin, Ireland, conducting genomics research to examine the relationship between genetics, health, and disease. A wholly-owned subsidiary of US biotech HiberCell Inc., Genuity Science builds a controlled genomic and health data platform used by commercial partners and academic research groups to accelerate drug discovery.

Summary

GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord)) is a Biotech company based in Cambridge, United States. It has raised $530.0M in total across 4 rounds, most recently a $200.0M Series C round in Nov 2018. Investors include Yunfeng Capital, Temasek and Sequoia Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionAug 2021

Sign up to see all 5 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
GRAILIPO

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Menlo Park, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$2.1BJun 2026
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord)) on Indexed.vc
<a href="https://indexed.vc/companies/gs-holdings-formerly-genuity-science-wuxi-nextcode-genomics-fjord"><img src="https://indexed.vc/api/badge/company/gs-holdings-formerly-genuity-science-wuxi-nextcode-genomics-fjord" alt="GS Holdings (formerly Genuity Science (WuXi Nextcode Genomics – Fjord)) on Indexed.vc" width="260" height="76" /></a>